MFN2 and acute myeloid leukemia: We investigated the impact of targeted suppression of several key effectors of mitochondrial membrane fusion/fission, including MFN1, MFN2 and OPA1 (pro-fusion), and MFF and DRP1 (pro-fission), in AML PDXs and cell lines.